Mazen Animal Health, an animal health company developing maize-based vaccines, announced it has been issued a patent from the U.S. Patent and Trademark Office for its technology to produce orally delivered animal vaccines. The patent covers foundational technology for the company’s first vaccine product for Porcine Epidemic Diarrhea Virus, according to a news release. The virus is […]
Mazen, an animal health company developing oral vaccines administered through animal feed, announced the closing of its Series A funding round, in which it raised $11.2 million. According to a release, Mazen’s technology eliminates issues associated with injectable vaccines like higher costs and the need for labor. “Our investors are seeing the tremendous potential of the technology […]